Sprycel (dasatinib) Information
Sprycel (dasatinib) is a drug used to treat certain adult patients with Philadelphia chromosome-positive chronic myeloid leukemia (CML) or acute lymphoblastic leukemia (ALL).
Adverse reactions or quality problems experienced with the use of this product may be reported to the FDA's MedWatch Adverse Event Reporting program using the contact information at the bottom of this page.
Related Information
- FDA Drug Safety Communication: Sprycel (dasatinib) and risk of pulmonary arterial hypertension
- FDA Drug Safety Podcast for Healthcare Professionals: Sprycel (dasatinib) and risk of pulmonary arterial hypertension